Electrolyte Blood Press.  2007 Jun;5(1):42-46. 10.5049/EBP.2007.5.1.42.

Metabolic Acidosis in Maintenance Hemodialysis Patients: Clinical Impact and Intervention

• Kim HJ
• Han SW

• KMID: 2134804
• DOI: http://doi.org/10.5049/EBP.2007.5.1.42

Abstract

Metabolic acidosis has been considered as one of the reverse epidemiologic factors for the morbidity and mortality in maintenance hemodialysis patients (MHP). Expectedly, in the recent large scale epidemiologic study (The Dialysis Outcome Practice Pattern Study, DOPPS), a mild to moderate degree of predialysis metabolic acidosis has shown better nutritional status and lower relative risk for mortality and hospitalization in MHP. Similarly, another recent study of the largest sample size of MHP of more than 55,000 revealed the lowest unadjusted mortality with mild to moderate degree of predialysis HCO3 levels (17 to 23 mEq/L). However, it was reversed after case-mix and multivariate adjustment, including the malnutrition-inflammation complex syndrome, so that predialysis HCO3 levels of more than 22 mEq/L had a lower death risk. On view of this up-to-date on-going controversy about the optimal acid-base status for MHP, this paper will review the historical and break-through data about the pros and cons of metabolic acidosis published in the clinical human studies of MHP, a special subgroup of chronic kidney disease patients. Based on these results, if possible, we would like to suggest the best practice guideline, particularly, for the optimal predialysis HCO3 level, dialysate HCO3 concentration, and dietary protein intake.

MeSH Terms

Acidosis*
Dialysis
Dietary Proteins
Epidemiologic Factors
Hospitalization
Humans
Mortality
Nutritional Status
Practice Guidelines as Topic
Renal Dialysis*
Renal Insufficiency, Chronic
Sample Size
Dietary Proteins

Reference

1. Papadoyannakis NJ, Stefanidis CJ, McGeown M. The effect of the correction of metabolic acidosis on nitrogen and potassium balance of patients with chronic renal failure. Am J Clin Nutr. 1984; 40:623–627. PMID: 6089541.

2. Kraut JA, Mishler DR, Singer FR, Goodman WG. The effects of metabolic acidosis on bone formation and bone resorption in the rat. Kidney Int. 1986; 30:694–700. PMID: 3784302.

3. Ge YQ, Wu ZL, Xu YZ, Liao LT. Study on nutritional status of maintenance hemodialysis patients. Clin Nephrol. 1998; 50:309–314. PMID: 9840319.

4. Movilli E, Zani R, Carli O, Sangalli L, Pola A, Camerini C, Cancarini GC, Scolari F, Feller P, Maiorca R. Correction of metabolic acidosis increases serum albumin concentrations and decreases kinetically evaluated protein intake in haemodialysis patients: a prospective study. Nephrol Dial Transplant. 1998; 13:1719–1722. PMID: 9681718.

5. Kraut JA, Kurtz I. Metabolic acidosis of CKD: diagnosis, clinical characteristics, and treatment. Am J Kidney Dis. 2005; 45:978–993. PMID: 15957126.

6. Uribarri J, Levin NW, Delmez J, Depner TA, Ornt D, Owen W, Yan G. Association of acidosis and nutritional parameters in hemodialysis patients. Am J Kidney Dis. 1999; 34:493–499. PMID: 10469860.

7. Dumler F, Falla P, Butler R, Wagner C, Francisco K. Impact of dialysis modality and acidosis on nutritional status. ASAIO J. 1999; 45:413–417. PMID: 10503617.

8. Gao H, Lew SQ, Bosch JP. Moderate metabolic acidosis and its effects on serum parameters in hemodialysis patients. Nephron. 2000; 86:135–138. PMID: 11014982.

9. Leavey SF, Strawderman RL, Young EW, Saran R, Roys E, Agodoa LY, Wolfe RA, Port FK. Cross-sectional and longitudinal predictors of serum albumin in hemodialysis patients. Kidney Int. 2000; 58:2119–2128. PMID: 11044233.

10. Chauveau P, Fouque D, Combe C, Laville M, Canaud B, Azar R, Cano N, Aparicio M, Leverve X. Acidosis and nutritional status in hemodialyzed patients. French Study Group for Nutrition in Dialysis. Semin Dial. 2000; 13:241–246. PMID: 10923352.

11. Lin SH, Lin YF, Chin HM, Wu CC. Must metabolic acidosis be associated with malnutrition in haemodialysed patients? Nephrol Dial Transplant. 2002; 17:2006–2010. PMID: 12401862.

12. Bommer J, Locatelli F, Satayathum S, Keen ML, Goodkin DA, Saito A, Akiba T, Port FK, Young EW. Association of predialysis serum bicarbonate levels with risk of mortality and hospitalization in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2004; 44:661–671. PMID: 15384017.

13. Wu DY, Shinaberger CS, Regidor DL, McAllister CJ, Kopple JD, Kalantar-Zadeh K. Association between Serum Bicarbonate and Death in Hemodialysis Patients: Is It Better to Be Acidotic or Alkalotic? Clin J Am Soc Nephrol. 2006; 1:70–78. PMID: 17699193.

14. Soudan K, Ricanati ES, Leon JB, Sehgal AR. Determinants of metabolic acidosis among hemodialysis patients. Hemodial Int. 2006; 10:209–214. PMID: 16623676.

15. Mitch WE, Goldberg AL. Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. N Engl J Med. 1996; 335:1897–1905. PMID: 8948566.

16. Mitch WE. Metabolic acidosis stimulates protein metabolism in uremia. Miner Electrolyte Metab. 1996; 22:62–65. PMID: 8676827.

17. Eustace JA, Astor B, Muntner PM, Ikizler TA, Coresh J. Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease. Kidney Int. 2004; 65:1031–1040. PMID: 14871424.

18. Locatelli F, Fouque D, Heimburger O, Drueke TB, Cannata-Andia JB, Horl WH, Ritz E. Nutritional status in dialysis patients: a European consensus. Nephrol Dial Transplant. 2002; 17:563–572. PMID: 11917047.

19. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003; 42(Suppl 3):S1–S201. PMID: 14520607.

20. Blumenkrantz MJ, Kopple JD, Gutman RA, Chan YK, Barbour GL, Roberts C, Shen FH, Gandhi VC, Tucker CT, Curtis FK, Coburn JW. Methods for assessing nutritional status of patients with renal failure. Am J Clin Nutr. 1980; 33:1567–1585. PMID: 7395778.

21. Kalantar-Zadeh K, Block G, McAllister CJ, Humphreys MH, Kopple JD. Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients. Am J Clin Nutr. 2004; 80:299–307. PMID: 15277149.